MedTrace Logo

Hip Scope Fascia-iliaca (FI) Block Study

NCT02365961 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2019-03-14

Study results available
· View outcomes & findings →

Summary

Patients undergoing a hip scope procedure will be recruited for this study. They will be randomized to either receive a nerve block or no nerve block (pain medicine only). Pain levels and clinical outcomes will be assessed through 3 months post-operatively.

Conditions

  • Hip Dysplasia
  • Femoroacetabular Impingement
  • Acetabular Labrum Tear

Interventions

DRUG

ropivicaine

DRUG

clonidine

DRUG

Epinephrine

DRUG

Noropin

Sponsors & Collaborators

  • The Hawkins Foundation

    lead OTHER

Principal Investigators

  • Eugene Kim, MD · Greenville Anesthesiology - Greenville Health System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02365961 on ClinicalTrials.gov